首页> 外文期刊>Revista de microbiologia >Enzootic bovine Leukosis: development of an indirect enzyme linked immunosorbent assay (I-Elisa) in seroepidemiological studies
【24h】

Enzootic bovine Leukosis: development of an indirect enzyme linked immunosorbent assay (I-Elisa) in seroepidemiological studies

机译:牛牛白血病:血清流行病学研究中间接酶联免疫吸附测定(I-Elisa)的发展

获取原文
           

摘要

Bovine Leukemia Virus (BLV) is the etiologic agent of Enzootic Bovine Leukosis, a retrovirus exogenous to the bovine species. Once infected, there is no detectable viraemia but instead there is a strong and persistent immunological response to BLV structural proteins, essentially the gp51 envelope glycoprotein and the mayor core protein p24. We describe the test procedure of an indirect ELISA (I-ELISA) using polyclonal reagents for the detection of antibodies to BLV. For comparison, the sera were simultaneously tested by agar gel immunodiffussion (AGID) test, which is currently used as diagnostic standard for BLV infection. The antigen applied does not require a high degree of purification and the data from the analysis of the negative sera showed that the establishment of a cut-off level corresponding to 3 times the standard deviation (SD) above the mean for the negative control set of sera provided acceptable specificity, reducing the risk of false positives results. A comparison of the results obtained by AGID test and I-ELISA showed that considering a total of 465 serum samples, all of the 234 samples (50%) that were positive by AGID were positive to the I-ELISA. Of 225 serum samples which yielded negative results in the AGID test, 69 (15%) were found to be positive by the I-ELISA and 156 (33%) were negative by both techniques. Few sera (2%) that were non-specific by AGID were defined as negative or positive by I-ELISA.
机译:牛白血病病毒(BLV)是Enzootic牛白血病的病原体,这是牛种的外源逆转录病毒。一旦感染,就没有可检测到的病毒血症,而是对BLV结构蛋白(主要是gp51包膜糖蛋白和市长核心蛋白p24)产生了强而持久的免疫应答。我们描述了使用多克隆试剂检测针对BLV的抗体的间接ELISA(I-ELISA)的测试程序。为了进行比较,同时通过琼脂凝胶免疫扩散(AGID)测试同时检测血清,该测试目前用作BLV感染的诊断标准。所施加的抗原不需要高度纯化,并且阴性血清分析的数据表明,临界水平的建立对应于阴性对照组平均值的3倍标准偏差(SD)。血清提供了可接受的特异性,降低了假阳性结果的风险。通过AGID测试和I-ELISA获得的结果的比较表明,考虑到总共465个血清样品,AGID阳性的234个样品(50%)全部对I-ELISA呈阳性。在225份血清样本中,在AGID测试中产生阴性结果,通过I-ELISA检测到69份(15%)为阳性,两种技术均发现156份(33%)为阴性。通过I-ELISA将AGID非特异性的血清(2%)定义为阴性或阳性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号